Gender differences in stroke, mortality, and hospitalization among patients with atrial fibrillation: A systematic review

Heart and Lung: Journal of Acute and Critical Care

Volumn 44, Issue 3, 2015, Pages 189-198

  Chapa, Deborah W ^a   Akintade, Bimbola ^b   Thomas, Sue A ^b   Friedmann, Erika ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

Author keywords

Atrial fibrillation; Female; Stroke; Survival; Systematic review

Indexed keywords

AGE DISTRIBUTION; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DATA BASE; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; MEDICAL LITERATURE; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; ATRIAL FLUTTER; COMPLICATION; MORTALITY; PREVALENCE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; STROKE;

ATRIAL FIBRILLATION; ATRIAL FLUTTER; FEMALE; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SEX FACTORS; STROKE;

EID: 84929503720     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2015.01.008     Document Type: Review

References (48)

1. Heeringa J., van der Kuip D.A., Hofman A., et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006, 27(8):949-953.
2. Shea J.B., Sears S.F. Apatient's guide to living with atrial fibrillation. Circulation 2008, 117(20):e340-e343.
3. Wyse D.G., Waldo A.L., DiMarco J.P., et al. Acomparison of rate control and rhythm control in patients with atrial fibrillation. NEngl J Med 2002, 347(23):1825.
4. Curtis A.B., Gersh B.J., Corley S.D., et al. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005, 149(4):645-649.
5. Shea J.B., Maisel W.H. Cardioversion. Circulation 2002, 106(22):e176-e178.
6. Waktare J.E. Atrial fibrillation. Circulation 2002, 106(1):14-16.
7. Coyne K.S., Paramore C., Grandy S., Mercader M., Reynolds M., Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 2006, 9(5):348-356.
8. Wolf P.A., Mitchell J.B., Baker C.S., Kannel W.B., D'Agostino R.B. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998, 158(3):229.
9. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults. JAm Med Assoc 2001, 285(18):2370-2375.
10. Colissa S., Crow A., Petkun W., et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 2013, 112(8):1142-1145.
11. Lloyd-Jones Donald M., Wang T.J., Leip E.P., et al. Lifetime risk for development ofatrial fibrillation the Framingham heart study. Circulation 2004, 110(9):1042-1046.
12. Humphries K.H., Jackevicius C., Gong Y., et al. Population rates of hospitalization for atrial fibrillation/flutter in Canada. Can J Cardiol 2004, 20(9):869-876.
13. Ferrari R., Abergel H., Ford I., et al. Gender-and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol 2013, 167(6):2938-2943.
14. Anand S., Xie C., Mehta S., et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. JAm Coll Cardiol 2005, 46(10):1845-1851.
15. Glaser R., Selzer F., Jacobs A.K., Laskey W.K. Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes. Am J Cardiol 2006, 98(11):1446-1450.
16. Akintade B.F., Chapa D., Friedmann E., Thomas S.A. The influence of depression and anxiety symptoms on health-related quality of life in patients with atrial fibrillation and atrial flutter. JCardiovasc Nurs 2015, 66-73.
17. Chapa D.W., Akintade B., Schron E., Friedmann E., Thomas S.A. Is health-related quality of life a predictor of hospitalization or mortality among women or men with atrial fibrillation. JCardiovasc Nurs 2014, 29(6):555-564.
18. Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009, 151(4):W-65.
19. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151(4):264-269.
20. Quality assessment tool for quantitative studies Effective Public Health Practice Project, Webpage. Available at: URL, Accessed 22.06.13. http://www.hamilton.ca/HealthandSocialServices/Research/EPHPP/.
21. Armijo-Olivo S., Stiles C.R., Hagen N.A., Biondo P.D., Cummings G.G. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. JEval Clin Pract 2012, 18(1):12-18.
22. Thomas B.H., Ciliska D., Dobbins M., Micucci S. Aprocess for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 2004, 1(3):176-184.
23. Ford G.A., Choy A.M., Deedwania P., et al. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials. Stroke 2007, 38(11):2965-2971.
24. Gomberg-Maitland M., Wenger N.K., Feyzi J., et al. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J 2006, 27(16):1947-1953.
25. Asbach S., Olschewski M., Faber T.S., Zehender M., Bode C., Brunner M. Mortality in patients with atrial fibrillation has significantly decreased during the last three decades: 35 years of follow-up in 1627 pacemaker patients. Europace 2008, 10(4):391-394.
26. Rienstra M., Van Veldhuisen D.J., Hagens V.E., et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control versus Electrical Cardioversion (RACE) study. JAm Coll Cardiol 2005, 46(7):1298-1306.
27. Dagres N., Nieuwlaat R., Vardas P.E., et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. JAm Coll Cardiol 2007, 49(5):572-577.
28. Avgil Tsadok M., Jackevicius C.A., Rahme E., Humphries K.H., Behlouli H., Pilote L. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAm Med Assoc 2012, 307(18):1952-1958.
29. 2 scoring system. JCardiovasc Electrophysiol 2012, 23(2):155-162.
30. Shen A.Y., Yao J.F., Brar S.S., Jorgensen M.B., Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. JAm Coll Cardiol 2007, 50(4):309-315.
31. Fang M.C., Singer D.E., Chang Y., et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors in Atrial fibrillation (ATRIA) study. Circulation 2005, 112(12):1687-1691.
32. Poli D., Antonucci E., Grifoni E., Abbate R., Gensini G.F., Prisco D. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Thromb Haemost 2009, 101(5):938-942.
33. Friberg J., Scharling H., Gadsboll N., et al. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol 2004, 94(7):889-894.
34. Friberg L., Benson L., Rosenqvist M., Lip G. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 2012, 344.
35. Poli D., Antonucci E., Testa S., et al. Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Thromb Res 2013 Jan, 131(1):12-16.
36. Inoue H., Atarashi H., Okumura K., et al. Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation. Am J Cardiol 2014, 113(6):957-962.
37. Melgaard L., Rasmussen L.H., Skjoth F., Lip G.Y., Larsen T.B. Age dependence of risk factors for stroke and death in young patients with atrial fibrillation: a nationwide study. Stroke 2014, 45(5):1331-1337.
38. Salam A., AlBinali H.A., Al-Mulla A.W., et al. Women hospitalized with atrial fibrillation: gender differences, trends and outcome from a 20-year registry in a Middle Eastern country (1991-2010). Int J Cardiol 2013 Sep30, 168(2):975-980.
39. Wang T., Massaro J.M., Levy D., et al. Arisk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAm Med Assoc 2003, 290(8):1049-1056.
40. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAm Med Assoc 2001, 285(22):2864-2870.
41. Camm A.J., Kirchhof P., Lip G.Y.H., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31(19):2369-2429. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery.
42. Patel D., Mohanty P., Di Biase L., et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010, 7(2):167-172.
43. Arias E. United States live tables2009. Natl Vital Stat Rep 2014, 62(7):1-63.
44. Guyatt G.H., Oxman A.D., Montori V., et al. GRADE guidelines: rating the quality of evidence of publication bias. JClin Epidemiol 2011, 64(12):1277-1282.
45. Pham B., Klassen T.P., Lawson M.L., Moher D. Language of publication restrictions in systematic reviews gave different results depending on whether the intervention was conventional or complementary. JClin Epidemiol 2005, 58(8):769-776.
46. Larsson S. Healthy lifestyle cut stroke risk in half for women. Neurology 2014, 83(19):1699-1704.
47. Le Heuzey J.Y., Paziaud O., Piot O., et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J 2004, 147(1):121-126.
48. Stewart S., Murphy N., Walker A., McGuire A., McMurray J.J.V. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004, 90(3):286-292.